Showing 1 - 5 results of 5 for search 'Jean-Marie Nogaret', query time: 0.03s Refine Results
  1. 1
    Use of lymphoscintigraphy to differentiate primary versus secondary lower extremity lymphedema after surgical lymphadenectomy: a retrospective analysis

    Use of lymphoscintigraphy to differentiate primary versus secondary lower extremity lymphedema after surgical lymphadenectomy: a retrospective analysis by Mirela Mariana Roman, Romain Barbieux, Jean-Marie Nogaret, Pierre Bourgeois

    Published 2018-04-01
    Get full text
    Article
  2. 2
    Near-Infrared Fluorescence Imaging of Breast Cancer and Axillary Lymph Nodes After Intravenous Injection of Free Indocyanine Green

    Near-Infrared Fluorescence Imaging of Breast Cancer and Axillary Lymph Nodes After Intravenous Injection of Free Indocyanine Green by Pierre Bourgeois, Isabelle Veys, Danielle Noterman, Filip De Neubourg, Marie Chintinne, Sophie Vankerckhove, Jean-Marie Nogaret

    Published 2021-03-01
    Get full text
    Article
  3. 3
    ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy.

    ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy. by Isabelle Veys, Catalin-Florin Pop, Romain Barbieux, Michel Moreau, Danielle Noterman, Filip De Neubourg, Jean-Marie Nogaret, Gabriel Liberale, Denis Larsimont, Pierre Bourgeois

    Published 2018-01-01
    Get full text
    Article
  4. 4
    Intraoperative electron radiotherapy in early invasive ductal breast cancer: 6-year median follow-up results of a prospective monocentric registry

    Intraoperative electron radiotherapy in early invasive ductal breast cancer: 6-year median follow-up results of a prospective monocentric registry by Catherine Philippson, Samuel Larsen, Stéphane Simon, Christophe Vandekerkhove, Alex De Caluwe, Dirk Van Gestel, Marie Chintinne, Isabelle Veys, Filip De Neubourg, Danièle Noterman, Mirela Roman, Jean-Marie Nogaret, Antoine Desmet

    Published 2022-11-01
    Get full text
    Article
  5. 5
    Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer.

    Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer. by Michail Ignatiadis, Dimitrios Zardavas, Marc Lemort, Celine Wilke, Marie-Catherine Vanderbeeken, Veronique D'Hondt, Evandro De Azambuja, Andrea Gombos, Fabienne Lebrun, Lissandra Dal Lago, Fanny Bustin, Marion Maetens, Lieveke Ameye, Isabelle Veys, Stefan Michiels, Marianne Paesmans, Denis Larsimont, Christos Sotiriou, Jean-Marie Nogaret, Martine Piccart, Ahmad Awada

    Published 2016-01-01
    Get full text
    Article

Search Tools: